Accuracy of Accuhaler Tester, Ellipta Tester and Turbutester in Patients With Chronic Obstructive Pulmonary Disease - Trial NCT06346678
Access comprehensive clinical trial information for NCT06346678 through Pure Global AI's free database. This phase not specified trial is sponsored by Thammasat University and is currently Not yet recruiting. The study focuses on Chronic Obstructive Pulmonary Disease. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Thammasat University
Timeline & Enrollment
N/A
Apr 16, 2024
Oct 31, 2024
Primary Outcome
Accuracy of Accuhaler tester,Accuracy of Ellipta tester,Accuracy of Turbutester
Summary
The goal of this observational study is to investigate the accuracy of Accuhaler tester,
 Ellipta tester and Turbutester in patients with chronic obstructive pulmonary disease (COPD).
 The main question it aims to answer is:
 
 • Do Accuhaler tester, Ellipta tester, and Turbutester demonstrate comparable accuracy to the
 In-check DIAL for assessing inspiratory inhalation force in COPD patients?
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06346678
Non-Device Trial